Prediction of Human Induced Pluripotent Stem Cell Cardiac Differentiation Outcome by Multifactorial Process Modeling

Human cardiomyocytes (CMs) have potential for use in therapeutic cell therapy and high-throughput drug screening. Because of the inability to expand adult CMs, their large-scale production from human pluripotent stem cells (hPSC) has been suggested. Significant improvements have been made in underst...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Front Bioeng Biotechnol
Autors principals: Williams, Bianca, Löbel, Wiebke, Finklea, Ferdous, Halloin, Caroline, Ritzenhoff, Katharina, Manstein, Felix, Mohammadi, Samira, Hashemi, Mohammadjafar, Zweigerdt, Robert, Lipke, Elizabeth, Cremaschi, Selen
Format: Artigo
Idioma:Inglês
Publicat: Frontiers Media S.A. 2020
Matèries:
Bioengineering and Biotechnology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7390976/
https://ncbi.nlm.nih.gov/pubmed/32793579
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2020.00851
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars